APA (7th ed.) Citation

MA, S., R, L., P, N., A, C., M, F., D, F., . . . MC, P. (2005). Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome. Annals of hematology, 84(3), 167. https://doi.org/10.1007/s00277-004-0961-9

Chicago Style (17th ed.) Citation

MA, Spiriti, et al. "Impact of a New Dosing Regimen of Epoetin Alfa on Quality of Life and Anemia in Patients with Low-risk Myelodysplastic Syndrome." Annals of Hematology 84, no. 3 (2005): 167. https://doi.org/10.1007/s00277-004-0961-9.

MLA (9th ed.) Citation

MA, Spiriti, et al. "Impact of a New Dosing Regimen of Epoetin Alfa on Quality of Life and Anemia in Patients with Low-risk Myelodysplastic Syndrome." Annals of Hematology, vol. 84, no. 3, 2005, p. 167, https://doi.org/10.1007/s00277-004-0961-9.